Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Assets: 2010-2024

Historic Assets for Anika Therapeutics (ANIK) over the last 15 years, with Dec 2024 value amounting to $202.7 million.

  • Anika Therapeutics' Assets fell 18.14% to $189.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $189.4 million, marking a year-over-year decrease of 18.14%. This contributed to the annual value of $202.7 million for FY2024, which is 25.09% down from last year.
  • Anika Therapeutics' Assets amounted to $202.7 million in FY2024, which was down 25.09% from $270.6 million recorded in FY2023.
  • In the past 5 years, Anika Therapeutics' Assets ranged from a high of $365.6 million in FY2020 and a low of $202.7 million during FY2024.
  • Over the past 3 years, Anika Therapeutics' median Assets value was $270.6 million (recorded in 2023), while the average stood at $274.2 million.
  • In the last 5 years, Anika Therapeutics' Assets climbed by 10.55% in 2020 and then fell by 25.09% in 2024.
  • Yearly analysis of 5 years shows Anika Therapeutics' Assets stood at $365.6 million in 2020, then declined by 4.94% to $347.5 million in 2021, then climbed by 0.46% to $349.1 million in 2022, then decreased by 22.48% to $270.6 million in 2023, then fell by 25.09% to $202.7 million in 2024.